GSK Battles Back With Strong 2Q Results, Says 2012 Will Be A Transformational Year
This article was originally published in The Pink Sheet Daily
Executive Summary
After hitting a low point, GlaxoSmithKline believes its second quarter results reflect a turnaround for the company and the progress the company has made in strengthening it portfolio.